Ambulatory Electrocardiography Monitoring Devices – Market Insights – United States

While the global COVID-19 pandemic has impacted the ambulatory ECG monitoring device market, recovery has been quick. The market will be driven by a heightened interest in remote monitoring services, promising results of clinical trials in various indications, a shift toward office-based and service-based prescriptions, and advancements in AI and tech.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ambulatory ECG monitoring devices in the US from 2019 through 2031.

New device approvals and other events are impacting the market share dynamics of the ambulatory ECG monitoring device market.

How are competitors adjusting their strategies to remain competitive in the ever-developing ambulatory ECG monitoring device market?

What mergers and acquisitions are occurring in the ambulatory ECG monitoring device space, and how are they impacting competitors?

What kinds of new devices are entering the ambulatory ECG monitoring device market, and how will they affect market and competitive dynamics?

Technical advancements and increased competition will affect the ambulatory ECG monitoring device market throughout the forecast period.

What affect will advancements in tech and AI have on the ambulatory ECG monitoring device market?

How will the landscape of the ambulatory ECG monitoring device market change due to new algorithms, including the integration of cloud-based servers?

Will smart wearables and other innovations compete with the ambulatory ECG monitoring market?

The COVID-19 global pandemic has had a dual effect on the ambulatory ECG monitoring device market in the short term.

At what pace has the ambulatory ECG monitoring device market recovered?

To what extent did the COVID-19 pandemic impact the different segments of the ambulatory ECG monitoring device market?

What long-term effects did the COVID-19 pandemic have on the adoption of ambulatory ECG monitoring devices?

How is the mix of ambulatory ECG monitoring devices changing over time?

Which monitoring device segments will experience the fastest growth? What device segments will be cannibalized by the adoption of newer types of longer term monitoring?

What barriers, such as restrictive reimbursement policies, hinder the adoption of newer types of monitoring?

How will the shift toward service-based prescriptions impact the market?

Table of contents